INVO Fertility, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
INVO Fertility, Inc. (IVF) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 9.05 thousand shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-06-02.
Financial Statements › Shareholders' Equity › Shares Granted or Issued, Share-Based Payment Arrangement › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-06-02
- INVO Fertility, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was -352.95K shares.
- INVO Fertility, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2023-12-31 was 0.00 shares, a 100.00% decline year-over-year.
- INVO Fertility, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2023-09-30 was 0.00 shares.
- INVO Fertility, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2023-06-30 was -85.56K shares, a 670.39% decline year-over-year.
- INVO Fertility, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 9.05K shares.
- INVO Fertility, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 59.05K shares, a 86.99% decline from fiscal 2022.
- INVO Fertility, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 453.71K shares, a 152.35% increase from fiscal 2021.
- INVO Fertility, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2021 was 179.80K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|---|
| 2025-12-31 | -352.95K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-02 | 9.05K shares 10-K · filed 2026-06-02 | |||
| 2025-09-30 | 362.00K shares 10-Q · filed 2025-11-17 | ||||
| 2025-08-25 | 9.05K shares 10-K · filed 2026-06-02 | ||||
| 2023-12-31 | 0.00 shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-11-19 | 0.00 shares derived: sum of 2 quarters · filed 2024-11-19 | -85.56K shares derived: sum of 3 quarters · filed 2024-11-19 | 59.05K shares 10-K/A · filed 2024-11-19 | |
| 2023-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -85.56K shares derived: sum of 2 quarters · filed 2023-11-13 | 59.05K shares 10-Q · filed 2023-11-13 | 79.05K shares derived: sum of 4 quarters · filed 2023-11-13 | |
| 2023-06-30 | -85.56K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | 59.05K shares 10-Q · filed 2023-08-14 | 79.05K shares derived: sum of 3 quarters · filed 2023-08-14 | 79.05K shares derived: sum of 4 quarters · filed 2023-08-14 | |
| 2023-03-31 | 144.61K shares 10-Q · filed 2023-05-15 | 164.61K shares derived: sum of 2 quarters · filed 2023-05-15 | 164.61K shares derived: sum of 3 quarters · filed 2023-05-15 | 179.61K shares derived: sum of 4 quarters · filed 2023-05-15 | |
| 2022-12-31 | 20.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | 20.00K shares derived: sum of 2 quarters · filed 2023-04-17 | 35.00K shares derived: sum of 3 quarters · filed 2023-04-17 | 453.71K shares 10-K · filed 2023-04-17 | |
| 2022-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | 15.00K shares derived: sum of 2 quarters · filed 2022-11-14 | 433.71K shares 10-Q · filed 2022-11-14 | 433.71K shares derived: sum of 4 quarters · filed 2022-11-14 | |
| 2022-06-30 | 15.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | 433.71K shares 10-Q · filed 2022-08-15 | 433.71K shares derived: sum of 3 quarters · filed 2022-08-15 | 433.71K shares derived: sum of 4 quarters · filed 2022-08-15 | |
| 2022-03-31 | 418.71K shares 10-Q · filed 2022-05-16 | 418.71K shares derived: sum of 2 quarters · filed 2022-05-16 | 418.71K shares derived: sum of 3 quarters · filed 2022-05-16 | 89.95K shares derived: sum of 4 quarters · filed 2022-05-16 | |
| 2021-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | 0.00 shares derived: sum of 2 quarters · filed 2022-03-31 | -328.76K shares derived: sum of 3 quarters · filed 2022-03-31 | 179.80K shares 10-K · filed 2022-03-31 | |
| 2021-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | -328.76K shares derived: sum of 2 quarters · filed 2021-11-15 | 179.80K shares 10-Q · filed 2021-11-15 | ||
| 2021-06-30 | -328.76K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | 179.80K shares 10-Q · filed 2021-08-16 | |||
| 2021-03-31 | 508.56K shares 10-Q · filed 2021-05-17 | ||||
| 2020-11-27 | 5.79K shares 10-K · filed 2021-03-30 | ||||
| 2020-10-16 | 202.60K shares 10-K · filed 2021-03-30 | ||||
| 2020-08-11 | 162.50K shares 10-K · filed 2021-03-30 | ||||
| 2020-04-06 | 938.00 shares 10-K · filed 2021-03-30 | ||||
| 2020-03-23 | 12.50K shares 10-K · filed 2021-03-30 | ||||
| 2020-02-05 | 15.49K shares 10-K · filed 2021-03-30 | ||||
| 2020-02-01 | 9.38K shares 10-K · filed 2021-03-30 | ||||
| 2020-01-17 | 125.00K shares 10-K · filed 2021-03-30 | ||||
| 2020-01-06 | 2.50K shares 10-K · filed 2021-03-30 | ||||
| 2019-10-29 | 30.07K shares 10-K · filed 2021-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |